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Abstract
Postpartum psychiatric disorders are heritable, but how genetic liability varies by other signiﬁcant risk factors is
unknown. We aimed to (1) estimate associations of genetic risk scores (GRS) for major depression (MD), bipolar
disorder (BD), and schizophrenia (SCZ) with postpartum psychiatric disorders, (2) examine differences by prior
psychiatric history, and (3) compare genetic and familial risk of postpartum psychiatric disorders. We conducted a
nested case-control study based on Danish population-based registers of all women in the iPSYCH2012 cohort who
had given birth before December 31, 2015 (n= 8850). Cases were women with a diagnosed psychiatric disorder or a
ﬁlled psychotropic prescription within one year after delivery (n= 5829 cases, 3021 controls). Association analyses
were conducted between GRS calculated from Psychiatric Genomics Consortium discovery meta-analyses for MD, BD,
and SCZ and case-control status of a postpartum psychiatric disorder. Parental psychiatric history was associated with
postpartum psychiatric disorders among women with previous psychiatric history (OR, 1.14; 95% CI 1.02–1.28) but not
without psychiatric history (OR, 1.08; 95% CI: 0.81–1.43). GRS for MD was associated with an increased risk of
postpartum psychiatric disorders in both women with (OR, 1.44; 95% CI: 1.19–1.74) and without (OR, 1.88; 95% CI:
1.26–2.81) personal psychiatric history. SCZ GRS was only minimally associated with postpartum disorders and BD GRS
was not. Results suggest GRS of lifetime psychiatric illness can be applied to the postpartum period, which may
provide clues about distinct environmental or genetic elements of postpartum psychiatric disorders and ultimately
help identify vulnerable groups.
Introduction
The postpartum period is one of the most vulnerable
times for psychiatric illness in a woman’s life1–3 and is
associated with a highly increased risk of depression and
other disorders3–8. Postpartum psychiatric disorders vary
in prevalence, severity, and timing of onset, and have a
wide spectrum of clinical symptoms9–13. They include
unipolar depression, which is common and occurs in
~10–15% of postpartum women14 and more rare and
severe disorders like bipolar disorder occurring in 3% of
postpartum women15, and postpartum psychosis that
occurs in 1 to 2 per 1000 in the ﬁrst few weeks after
delivery3,16,17. Personal2,4–6,18,19 and family history20–26 of
psychiatric illness are two of the strongest risk factors for
postpartum psychiatric disorders. A strong association
between family history and postpartum psychiatric dis-
orders suggests genetic vulnerability for these disorders,
which has been conﬁrmed in a recent heritability study of
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perinatal depression27. Moreover, heritability of post-
partum depression may be greater than that of major
depression outside of the perinatal period (44% versus
32%)27.
Genetic liability can be estimated as genetic risk scores
(GRS), a score produced for each individual by weighting
the effect size of multiple risk alleles obtained from
genetic association studies28. Increasingly robust ﬁndings
from genetic association studies have been used to con-
struct GRS for major depression (MD)29, bipolar disorder
(BD)30, and schizophrenia (SCZ)31 and evaluate shared
genetic risk between psychiatric traits32–34. Thus far, a
single study has considered GRS and risk of postpartum
depression and found that BD GRS was more strongly
associated with postpartum depression than major
depression outside the postpartum period (R2= 1.64%,
p= 3.04 × 10−5 versus R2= 0.4%, p= 0.02)35. While
genetic risk scores have been applied to postpartum
psychiatric disorders to evaluate genetic overlap with
other psychiatric disorders35, they have not been used to
explore how these correlations differ by other risk factors.
Assessing how genetic liability varies by speciﬁc and sig-
niﬁcant risk factors may help identify subgroups with
shared etiology.
We aimed to determine whether genetic risk scores for
MD, BD, and SCZ predict psychiatric disorders occurring
speciﬁcally in the postpartum period. Building on prior
work, we also sought to examine how risk score predic-
tions differ in women with a prior psychiatric history or
without, and how genetic risks compare to risks asso-
ciated with family history of psychiatric disorders.
Materials and methods
Study design
Data from Danish population-based registers were
linked by unique personal identiﬁcation numbers,
which are assigned to all live-born children and new
residents in Denmark and enable linkage across all
national registers. We conducted a case-control study
selected from the larger iPSYCH2012 study sample, for
which sample selection36 and genetic analytic meth-
ods34 have been described elsewhere (Supplementary
Methods). Brieﬂy, the iPSYCH2012 sample was selected
from the Danish Civil Registration System36 of all sin-
gleton births born between May 1st, 1981 and
December 31st, 2005 who were alive and resided in
Denmark at one year of age and whose mother was
known. The full cohort was then linked to the Danish
Psychiatric Central Research Register37. All subjects
within the full cohort who had a diagnosis of SCZ,
autism spectrum disorder, attention-deﬁcit/hyper-
activity disorder, BD, and affective disorder were
identiﬁed as cases in the iPSYCH2012 sample (N=
57,377). A random sample of 30,000 subjects (i.e., the
subcohort), was selected from the full cohort from
which the cases were drawn (Fig. 1)36. This random
sample represents a population sample to be used as
controls in the genetic analysis. However, since these
30,000 subjects were chosen randomly from the full
cohort, some also have psychiatric disorders.
Study population
For the current study, eligible study subjects were all
women born during 1981–1999 and included in the
iPSYCH2012 study sample who gave birth to at least one
child before December 31st, 2015 and passed genetic
quality control (N= 8931) (Fig. 1). We excluded 11
women who emigrated before their ﬁrst delivery and 70
women that could not be linked to their fathers in the
register. Altogether 8850 women were included in our
ﬁnal analysis.
Postpartum psychiatric disorders
We deﬁned a postpartum psychiatric disorder either as
(1) a treated psychiatric episode recorded in the Danish
Psychiatric Central Research Register or (2) at least one
redeemed prescription of psychotropic drugs recorded in
the Danish National Prescription Registry within
12 months after delivery. Consequently, our case group
consisted of moderate (prescription deﬁned) and severe
(treated in secondary health care and diagnosed by a
psychiatrist) cases (Supplementary Table S1). We selected
the time period of interest as one year after childbirth to
account for a potential delay in seeking psychiatric care
and to apply a widely used clinical deﬁnition38. Prior work
in these data showed similar familial risk of postpartum
psychiatric disorders at 3, 6, and 12 months postpartum39.
A postpartum psychiatric episode may represent a new-
onset disorder, a continuation or recurrence of a
psychiatric disorder prior to childbirth, or a different
psychiatric disorder after childbirth in a woman who had
a prior psychiatric disorder.
The Danish Psychiatric Central Research Register con-
tains information on inpatient contacts at psychiatric
hospitals and psychiatric wards from 1969 onwards. Psy-
chiatric outpatient treatment and emergency room con-
tacts have been included since 199537. Treated psychiatric
episodes included any psychiatric diagnosis (Primary
diagnosis, ICD-10 codes F00–F99), excluding mental
retardation and substance abuse (ICD-10 codes F10–F19
and F70–F79). The Danish National Prescription Registry
was established in 1995, and contains information on all
prescriptions dispensed at community pharmacies in
Denmark40. We included psychotropic drugs of Anato-
mical Therapeutic Chemical (ATC) classiﬁcation codes
N05 (psycholeptics) and N06 (psychoanaleptics). Detailed
diagnostic codes and categorization are described in the
Supplementary Methods.
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Personal and parental psychiatric history
We deﬁned previous personal psychiatric history as one in-
patient or out-patient treatment for the psychiatric disorders
described above or one redeemed prescription for psycho-
tropic medications before the date of delivery. We similarly
deﬁned parental psychiatric history as one in-patient or out-
patient treatment for psychiatric disorders in a mother or
father before the date of delivery. Note, as information on
prescriptions only dates back to 1995, prescription data were
not used to deﬁne parental psychiatric history.
Genotyping, quality control, and imputation
The Danish Newborn Screening Biobank stored dried
blood spots taken at birth from nearly all infants born in
Denmark since May 1st 198141. Genetic data were
extracted from the dried blood spot samples stored in this
biobank, whole-genome ampliﬁed (in triplicate using the
Qiagen REPLI-g mini kit and the three separate reactions
were pooled), and genotyped with Illumina Inﬁnium HD
Human610-Quad BeadChip42. Information about non-
genotyped markers was obtained by imputation using the
Fig. 1 Flowchart illustrating the identiﬁcation of the study population.
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1000 genomes phase 3 as reference panel. Quality control
and imputation were conducted using the Ricopili pipe-
line43 (Supplementary Methods).
Genetic risk scores
We calculated genetic risk scores for MD29, BD30, and
SCZ44 based on genome-wide data from Psychiatric
Genomics Consortium (PGC) discovery sample excluding
individuals in the iPSYCH2012 sample. We selected single
nucleotide polymorphisms (SNPs) associated with MD,
BP, and SCZ at a P-value threshold of 0.05 or lower, which
were reported as maximising out-of-sample prediction
into multiple cohorts of the study speciﬁc disorders
(Supplementary Table S2)44–46 and generated the poly-
genic risk score for each individual based on this
threshold (See Grove et al.34 and Supplementary Methods
for details).
Statistical analysis
Chi-squared tests were used to evaluate differences in
characteristics between cases and controls in the overall
cohort and among women with or without prior psy-
chiatric history, except in the case of maternal age at
index delivery, in which age distributions were compared
with t-tests. Binary logistic regression models were used
to estimate the odds ratios (ORs) of postpartum psy-
chiatric disorders with 95% conﬁdence intervals (CIs)
using Stata 13.1. We converted genetic risk scores into z-
scores according to the means and standard deviations
from the distributions in women born during 1981–1999
from the subcohort based on the following formula:
(observed value−mean)/standard deviation. We analyzed
standardized genetic risk scores as continuous variables,
reported as a unit change for one standard deviation or 10
deciles, and categorically by decile with the lowest decile
as the reference group. To account for ancestry differ-
ences, we adjusted for the ﬁrst four principal components
estimated from genome-wide SNP genotypes in all mod-
els47. To address the possible secular trends in diagnostic
practices and to account for the fact that fewer blood
spots were retrievable among women born in the earlier
years, we also included woman's calendar year of birth as a
covariate in all models. In the adjusted models, we
included parental psychiatric history before the index
delivery, parental country of origin, primiparity, age and
age-squared at the index delivery as additional covariates.
Because approximately 9% of the sample had a parent
born outside of Denmark, and thus, may be of mixed
ancestry, we conducted a sensitivity analysis restricting to
women only with parents of Danish origin. We present
results in the overall cohort but also stratiﬁed by women
with or without psychiatric history prior to childbirth, as
ﬁrst onset and recurrent postpartum psychiatric disorders
may reﬂect different phenotypes. We tested for statistical
interaction between GRS and psychiatric history to assess
whether the associations between GRS and postpartum
psychiatric disorders were modiﬁed by previous psychia-
tric history. To account for multiple corrections, we
applied a Bonferroni corrected P-value of 0.017 for α=
0.05 and three independent tests (MD, BD, and SCZ
GRS). We computed area under the covariate-adjusted
receiver-operator characteristic (ROC) curve to evaluate
the ability of the GRS for MD, BD, and SCZ to predict
postpartum psychiatric disorder case status.
Our primary outcome of interest was a psychiatric
disorder in the postpartum period, but to test to which
extent genetic risk scores in general predict psychiatric
disorders in our sample, we also conducted an analysis in
which cases consisted of psychiatric disorders at any time
point and controls were individuals free of psychiatric
disorders at any time.To determine whether results were
inﬂuenced by the P-value threshold used to select SNPs
from the discovery sample for inclusion in the risk score,
we repeated our analysis using all SNPs (PT ≤ 1). Because
our broad case deﬁnition might also inﬂuence results, we
conducted a sensitivity analysis in which we categorized
postpartum psychiatric disorders into two mutually
exclusive subsets deﬁned by severity of the postpartum
disorder: (1) hospital contact regardless of psychotropic
treatment and (2) only psychotropic medication use.
Ethics
The study was approved by the Danish Scientiﬁc Ethical
Committee System, the Danish Data Protection Agency,
and the Danish Neonatal Screening Biobank Steering
Committee. By Danish law, no informed consent is
required for a register-based study on the basis of anon-
ymized data. The study was also approved by the Insti-
tutional Review Board at the University of North Carolina
at Chapel Hill.
Results
The ﬁnal dataset consisted of 8850 women who had at
least one recorded childbirth. Median age was 25.0
(interquartile range: 23.0–28.8) years and the majority
were primiparous (64.4%). The sample included 479
postpartum psychiatric disorder cases and 1840 non-cases
among women with no previous personal psychiatric
history, and 2542 postpartum psychiatric disorder cases
and 3989 non-cases among women with previous perso-
nal psychiatric history (Table 1). Cases in the sample
consisted predominantly of those deﬁned by unipolar
depression diagnosis or redeemed prescription for anti-
depressants; 343 of 479 cases (71.6%) among women with
no previous personal psychiatric history, and 1540 of 2542
cases (60.6%) among women with previous personal
psychiatric history had either in- or outpatient treatment
for depression or redeemed prescription for
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antidepressants. Compared to non-cases, cases of post-
partum psychiatric disorders were more likely to have
parental psychiatric history (P < 0.001) and to be younger
(P < 0.001) and primiparous (P < 0.001).
After controlling for potential confounders, parental
psychiatric history was associated with a higher risk of
postpartum psychiatric disorders among women with
previous personal psychiatric history (OR: 1.14, 95% CI:
1.02–1.28) but not among women without personal psy-
chiatric history (OR: 1.08, 95% CI: 0.81–1.43). An
increased risk was observed in primiparous women, OR:
2.42 (95% CI: 2.14–2.74) and 1.63 (95% CI: 1.27–2.11) for
women with and without prior personal psychiatric his-
tory, respectively (Table 2) (Full model, Supplementary
Table S3).
Genetic risk score for MD signiﬁcantly predicted post-
partum psychiatric disorders as well as psychiatric dis-
orders at any time point. A 10-decile increase in MD GRS
was associated with an increased risk of postpartum
psychiatric disorders (OR: 1.73, 95% CI: 1.46–2.05), in
both women with no personal psychiatric history (OR:
1.88, 95% CI: 1.26–2.81) and women with personal psy-
chiatric history (OR: 1.44, 95% CI: 1.19–1.74). Risk of
postpartum psychiatric disorders was signiﬁcantly
increased for the highest deciles of MD GRS compared to
the lowest decile. (Table 3, Fig. 2a) (Full models in Sup-
plementary Tables S4, S5, S6; Models by decile, Supple-
mentary Table S7). Adjusted pseudo-R2 was 0.40% for
MD GRS among women with no prior personal psy-
chiatric history and 0.20% among women with previous
personal psychiatric history. Area under the covariate-
adjusted ROC curve (AUC) was 0.54 (95% CI: 0.52–0.58)
for MD GRS to predict postpartum psychiatric disorders
among women with no prior personal psychiatric history
and 0.52 (95% CI: 0.51–0.54) among women with pre-
vious psychiatric history (Fig. S1). Associations between
MD GRS and psychiatric disorders at any time (OR 2.48,
95% CI: 2.06–2.99) (Table 3; by decile, Supplementary
Table S8) were stronger than associations with post-
partum disorders (P-value for OR difference was 0.007).
We found no associations between GRS for BD and
postpartum psychiatric disorders, either overall or strati-
ﬁed by psychiatric history (Table 3, Fig. 2b). There was a
slight association between GRS for SCZ and postpartum
psychiatric disorders overall (Table 3, Fig. 2c). Pseudo-R2
for BD and SCZ GRS were small (Table 3) and AUC for
BD and SCZ GRS to predict postpartum psychiatric dis-
orders was smaller than that of MD GRS (Supplementary
Figs. S2, S3). In our analysis of cases of psychiatric dis-
orders at any time, we found GRS for BD and SCZ pre-
dicted psychiatric disorders, though less strongly than for
GRS MD.
We observed similar trends between GRS and post-
partum psychiatric disorders when we generated scores
from SNPs with P ≤ 1.0 in the GWAS training-set (Sup-
plementary Table S9). We found no signiﬁcant differences
when restricting only to women with parents of Danish
origin (Supplementary Table S10).
Discussion
Summary of results
In a large sample of women who had given birth, we
found that genetic risk score for lifetime MD was asso-
ciated with postpartum psychiatric episodes in both
women with no psychiatric history (OR: 1.88, 95% CI:
1.26–2.81 for a 10-decile increase in GRS) and women
with psychiatric history (OR: 1.44, 95% CI: 1.19–1.74 for a
10-decile increase in GRS). In contrast, we found no
signiﬁcant associations between BD risk scores and
postpartum psychiatric episodes. We found small asso-
ciations between SCZ risk scores and postpartum dis-
orders in the cohort unstratiﬁed by psychiatric history.
Previously identiﬁed risk factors for postpartum psychia-
tric disorders including primiparity and family history
were conﬁrmed in our sample.
Utility of a GRS
Prior studies have shown MD GRS based on the PGC
discovery sample to be a strong predictor of major
depression in several other target samples46 suggesting
the utility of MD GRS as a tool to investigate how addi-
tional risk factors may inﬂuence risk of MD in genetically
susceptible groups, as has been done for other disorders
such as schizophrenia48. As our cases predominantly
consist of depression diagnoses and women prescribed
antidepressants, it is encouraging that MD GRS predicts
psychiatric episodes in our target sample. However, both
the pseudo-R2 of MD GRS and AUC of MD GRS to
predict postpartum psychiatric episodes were small,
indicating that MD GRS should not yet be used in a
clinical setting to assess risk of postpartum psychiatric
episodes. Increasingly large MD discovery samples are
necessary to construct accurate predictive GRS, and
replication in multiple perinatal populations will be
required before GRS can be employed for screening or
therapeutic interventions.
Previously identiﬁed risk factors including primiparity
and family history of psychiatric disorders were conﬁrmed
in our sample. Information about these risk factors is
easily attained through patient inquiry and medical record
review and is currently the best information available for
evaluating risk of postpartum psychiatric disorders in a
clinical setting. Nonetheless, associations between MD
GRS and postpartum psychiatric disorders indicate that
the GRS may provide information about genetic liability
for psychiatric illness in addition to family history. In
particular, the effect of family history remains unchanged
with addition of a MD GRS into the model, and there are
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signiﬁcant independent associations of MD GRS with
postpartum psychiatric disorder case status in both
women with and women without prior personal psy-
chiatric history (Supplementary Table S4). In addition,
among women with no previous psychiatric history there
is an independent association of MD GRS with post-
partum psychiatric disorders, even in the absence of an
association of parental psychiatric history (Supplementary
Table S4), though this may be an artifact of greater sta-
tistical power to detect associations with GRS, a con-
tinuous variable, than parental psychiatric history, a
dichotomous variable.
The one other study applying GRS to postpartum psy-
chiatric disorders compared postpartum depression cases
to population controls and separately compared post-
partum depression cases to controls who had given birth.
They found that BD GRS explained more variance and
was more signiﬁcant for the subset of women who had
given birth than in the sample using population controls
(R2= 1.64%, P= 3.04 × 10−5 versus R2= 1.03%, P=
1.75 × 10−4)35. Importantly, adequate sample sizes of
genotyped cases of postpartum depression (PPD) for a
GWAS will enable construction of a PPD-speciﬁc GRS,
but in the meantime, our study provides evidence that
GRS for lifetime major depression can be applied in a
postpartum population. Although still infeasible for direct
application in a perinatal mental health clinical setting,
genetic risk scores are being used for research in several
disease areas to determine whether people in different
strata on the genetic risk distribution differ by response to
treatment49 or likelihood to be appropriately captured by
screening guidelines50 and are a step toward precision
medicine.
Comparison with previous results
Interestingly, we did not ﬁnd an expected association with
BD GRS. Prior epidemiologic work demonstrates post-
partum psychiatric illness may share more features with
bipolar disorder than other psychiatric disorders20–23,39,51,
particularly for postpartum psychosis7,52–55. In the study
applying genetic risk scores to PPD, Byrne et al. found a
stronger genetic relationship between PPD and BD than
PPD and MD by applying genetic risk scores for MD and
BD35. We hypothesize that the Byrne et al. ﬁndings were
not replicated in our sample for several reasons. First, case
and sample selection differed in the studies. Postpartum
psychiatric episodes are heterogeneous and the majority of
cases in our sample are most similar to major depression;
we would expect stronger associations with the MD GRS.
The outcome of PPD in Byrne et al. is also based primarily
on self-reported symptoms on the Edinburgh Postnatal
Depression Scale56 collected in community samples (i.e.,
not enriched for women seeking in- or out-patient treat-
ment). Second, since the Byrne et al. study was conducted,
larger MD GWAS sample sizes have identiﬁed new
genome-wide signiﬁcant loci, producing a more powerful
MD GRS that explains more variance in genetic liability.
Thus, the stronger associations with the MD GRS than BD
GRS may be due to the improved statistical power of the
MD score.
Table 2 Odds ratio for postpartum psychiatric disorders during the follow-up period according to baseline
characteristics
Characteristics Full cohort Women with no previous
psychiatric history
Women with previous psychiatric
history
Crude ORa
(95% CI)
Adjusted ORa,b
(95% CI)
Crude ORa
(95% CI)
Adjusted ORa,b
(95% CI)
Crude ORa
(95% CI)
Adjusted ORa,b
(95% CI)
Parental psychiatric history
No 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Yes 1.31 (1.19–1.45) 1.27 (1.14–1.41) 1.43 (1.11–1.84) 1.08 (0.81–1.43) 1.16 (1.04–1.30) 1.14 (1.02–1.28)
Parental country of origin
Denmark 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
At least one parent
outside Denmark
1.05 (0.86–1.27) 1.05 (0.85–1.29) 1.48 (0.94–2.31) 1.43 (0.86–2.36) 0.92 (0.74–1.15) 0.95 (0.76–1.20)
Primiparous
No 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Yes 2.88 (2.59–3.19) 2.44 (2.19–2.72) 2.58 (2.06–3.24) 1.63 (1.27–2.11) 2.83 (2.51–3.18) 2.42 (2.14–2.74)
aCalendar birth year of the woman and the ﬁrst four principal components were adjusted in the crude and adjusted odds ratio
bThe variables in the table were mutually adjusted and further adjusted for age and age squared in the adjusted OR
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Fig. 2 Odds ratio of postpartum psychiatric disorders by genetic risk scores for major depression, bipolar disorder, and schizophrenia.
Odds ratio of postpartum psychiatric disorders by amajor depression, b bipolar disorder, and c schizophrenia GRS decile with reference to the lowest
decile-panel among women with and with no psychiatric history before delivery. All are adjusted for calendar birth year of the woman, ﬁrst four
principal components, parental psychiatric history, parental country of origin, age and age squared at the index delivery, and primiparity
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Unique concerns and characteristics of investigating
genetic etiology of postpartum psychiatric disorders
We applied a broad case deﬁnition of postpartum psy-
chiatric disorders, comprising a spectrum of psychiatric
diagnoses identiﬁed by hospital diagnoses and psycho-
tropic prescriptions and occurring within the ﬁrst year
after childbirth. Although more heterogeneous, we
applied a broad deﬁnition to ensure we were capturing
cases that may be missed in hospital registries, examine
similarities and differences with other psychiatric dis-
orders, overcome sample size limitations, and provide a
comparable deﬁnition to other studies.
Prior studies suggest the etiology of psychiatric episodes
occurring immediately after childbirth may differ from
later psychiatric episodes3,7,23,51, and future work will
investigate potential underlying genetic differences as
sample sizes grow. Although the ﬁrst year postpartum
may not identify a speciﬁc etiologic cut-point, it is a
commonly used clinical deﬁnition of postpartum psy-
chiatric disorders38 and enables detection of women that
may delay seeking care. Additionally, in our prior work in
a similar cohort, we compared associations of family
psychiatric history and postpartum psychiatric disorders
at three, six, and twelve months after childbirth and found
few differences among the time points39, indicating it is
reasonable to assess genetic and familial predictors of
postpartum psychiatric disorders within the ﬁrst year after
childbirth in this setting. Including the entire ﬁrst year
postpartum can also improve statistical power. Although
our sample was selected from a large population-based
cohort, sample sizes of women who had given birth were
still relatively small.
In Denmark, 85–90% of ﬁrst depression treatment
among people aged 15–44 occurs in a primary care set-
ting57, and limiting our cases to only hospital-based psy-
chiatric diagnoses will underrepresent individuals
susceptible to mental illness, particularly depression.
Therefore, our deﬁnition of psychiatric disorders included
both hospital diagnosed cases and women who used
antidepressant medications. This broader deﬁnition aligns
with the concept of major depression operationalized by
the PGC, which was the source of the summary statistics
for the GRS scores. To better understand the genetic
architecture of depression and take advantage of existing
genomic resources, the PGC has adopted the concept of
‘major depression’ to establish case status, which includes
self-declared depression and is broader than major
depressive disorder meeting DSM criteria obtained by
clinical interview58. However, we also acknowledge that a
hospital-based diagnosis is more speciﬁc and anti-
depressant medications may be prescribed for conditions
other than depression. In Denmark, depression is recor-
ded as the indication for 59% of antidepressant prescrip-
tions57. Examining differences by case source may provide
information about how including psychotropic prescrip-
tions inﬂuence results and also genetic homogeneity by
severity, so we conducted a sensitivity analysis categoriz-
ing postpartum psychiatric disorders into those deﬁned by
hospital diagnosis (Supplementary Table S11a) and psy-
chotropic medication use (Supplementary Table S11b).
We found no strong evidence for heterogeneity by subset,
however, effect sizes were slightly larger for MD GRS
among those deﬁned only by psychotropic medication
use, further supporting the similarity of our deﬁnition
with that of major depression used by the PGC.
While most similar to major depression, our broad
deﬁnition of postpartum psychiatric disorders included a
spectrum of heterogeneous diagnoses that may have dif-
ferent underlying etiology. Prior work has shown that
these psychiatric disorders are genetically correlated59,
and GRS for one psychiatric disorder can be informative
for predicting another60, but we did not have ample sta-
tistical power to assess speciﬁc diagnoses separately.
There are several hypotheses about the development of
psychiatric disorders following childbirth. One is that
additional stressors of childbirth and the postpartum
period exacerbate an underlying vulnerability of mental
illness. Another is that some women are sensitive to
hormonal changes occurring near childbirth61–63. To
probe these hypotheses and consider childbirth as a
potential trigger, we investigated associations between
genetic vulnerability for psychiatric disorders and post-
partum disorders in the overall cohort and then stratiﬁed
by psychiatric history prior to childbirth. We found little
evidence of statistical differences by prior psychiatric
history, but we present stratiﬁed results because psy-
chiatric history is such a signiﬁcant risk factor for post-
partum psychiatric disorders6 and may provide insight
about new-onset postpartum disorders. Tests for inter-
action generally have low power to reject homogeneity64
but this is the largest existing study in this area, and
trends observed in women with and without prior psy-
chiatric history can provide the opportunity for compar-
ison in future studies.
In the analyses assessing the outcome of postpartum
psychiatric disorders in the full cohort and among women
with previous psychiatric history, the control groups
included women with psychiatric diagnoses prior to child-
birth, which is likely to weaken an association between MD
GRS and postpartum psychiatric episodes. Even within
these groups, we saw a signiﬁcant association which may
provide further evidence of enhanced genetic vulnerability
for postpartum psychiatric disorders. Postpartum disorders
were our primary outcome of interest, but to determine
how much limited power inﬂuenced the ability to detect
associations for BD and SCZ risk scores, and understand
how including women with psychiatric diagnoses as con-
trols may have inﬂuenced our results in women with
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previous psychiatric history, we conducted an additional
analysis comparing all women in our cohort with psychia-
tric disorders at any time (N= 7010) with all women
without any psychiatric history at any time (i.e., ‘clean
controls’) (N= 1840). We found that risk scores for BD and
SCZ did predict the outcome of lifetime psychiatric dis-
orders in our sample, however, associations were less strong
than for MD (Table 3, Supplementary Table S8).
We also found that associations between MD GRS and
psychiatric disorders were stronger for psychiatric dis-
orders at any time than in our primary analyses of post-
partum disorders. One might expect these associations to
be stronger and more precise since the sample is larger,
the controls contain no prior psychiatric episodes, and the
cases include women with psychiatric disorders before
childbirth, which may occur earlier and indicate greater
susceptibility to mental illness. Our results provide evi-
dence that the underlying genetic vulnerability of post-
partum disorders in our sample is most similar to that of
major depression, but we canot not determine if differ-
ences in strength of the associations are due to the sample
size, sampling framework, or underlying etiologic and
genetic differences. Future studies enabling an analysis of
a GRS speciﬁcally for postpartum psychiatric disorders
will help distinguish whether there are unique genetic
features of postpartum disorders and potentially identify
vulnerable risk groups both within and outside of the
postpartum period.
Strengths and Limitations
This study has several other limitations. The oldest
participants in our study are 34 years with a mean age of
25.9 years (SD 3.8), representing a relatively young cohort
that potentially limits generalizability to other age groups.
Additionally, most of the sample was primiparous, and
thus lifetime risk of postpartum psychiatric disorders
would not necessarily have been captured by these ﬁrst
births. The iPSYCH case selection inﬂuenced the pro-
portion and prevalence of speciﬁc psychiatric diagnoses in
the parent study36, resulting in more cases than controls
and a higher proportion of severe psychiatric disorders
(e.g., schizophrenia) compared to the general population.
Including antidepressant use in the case deﬁnition for the
present study consequently resulted in cases that were
primarily depression cases. Data for prescription use was
only available after 1995, so parental psychiatric history
was limited only to diagnosed psychiatric disorders, which
most likely represent more severe cases.
Despite these limitations, the study has a number of
strengths. This is the ﬁrst study to apply psychiatric GRS
in a population only of postpartum women. The study
uses objective and well-validated65–67 register-based
treated psychiatric episodes (i.e., diagnostic codes and
redeemed prescriptions) rather than self-reported
outcomes. Linkage with national registers also enables
assessment of additional risk factors such as prior psy-
chiatric history and family history. Finally, selection from
a nationally representative sample increases our general-
izability to broader populations, which is especially
important when assessing other risk factors in addition to
genetic liability.
Conclusions
We show evidence that genetic liability for major
depression is associated with postpartum psychiatric dis-
orders, suggesting genetic risk scores can provide addi-
tional information about risk not encompassed solely in
simple measures of family history, however, the predictive
ability of MD GRS to identify postpartum psychiatric
disorders was small. Our ﬁndings demonstrate that
although GRS is not yet appropriate as a clinical tool,
genetic information about the risk of lifetime psychiatric
illness can reasonably be applied to the postpartum period
in the research setting. As sample sizes of genetic studies
in postpartum populations grow, applying GRS to inves-
tigate shared genetic mechanisms may provide insight
into distinct attributes of postpartum disorders. If repli-
cated, our results could act as ﬁrst steps in guiding future
work focused on investigations that integrate studies in
genetic and environmental risk factors to ultimately
deﬁne vulnerable groups at risk for psychiatric disorders
following childbirth.
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